Meza-Zepeda L - Search Results

1

The architecture and evolution of cancer neochromosomes.

Garsed DW, Marshall OJ, Corbin VD, Hsu A, Di Stefano L, Schröder J, Li J, Feng ZP, Kim BW, Kowarsky M, Lansdell B, Brookwell R, Myklebost O, Meza-Zepeda L, Holloway AJ, Pedeutour F, Choo KH, Damore MA, Deans AJ, Papenfuss AT, Thomas DM. Garsed DW, et al. Cancer Cell. 2014 Nov 10;26(5):653-67. doi: 10.1016/j.ccell.2014.09.010. Epub 2014 Nov 10. Cancer Cell. 2014. PMID: 25517748 Free article.

2

HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.

Berner JM, Meza-Zepeda LA, Kools PF, Forus A, Schoenmakers EF, Van de Ven WJ, Fodstad O, Myklebost O. Berner JM, et al. Oncogene. 1997 Jun 19;14(24):2935-41. doi: 10.1038/sj.onc.1201135. Oncogene. 1997. PMID: 9205100

3

Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.

Forus A, Berner JM, Meza-Zepeda LA, Saeter G, Mischke D, Fodstad O, Myklebost O. Forus A, et al. Br J Cancer. 1998 Aug;78(4):495-503. doi: 10.1038/bjc.1998.521. Br J Cancer. 1998. PMID: 9716033 Free PMC article.

4

Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases.

Forus A, Larramendy ML, Meza-Zepeda LA, Bjerkehagen B, Godager LH, Dahlberg AB, Saeter G, Knuutila S, Myklebost O. Forus A, et al. Cancer Genet Cytogenet. 2001 Mar;125(2):100-11. doi: 10.1016/s0165-4608(00)00369-1. Cancer Genet Cytogenet. 2001. PMID: 11369052

5

Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions.

Meza-Zepeda LA, Berner JM, Henriksen J, South AP, Pedeutour F, Dahlberg AB, Godager LH, Nizetic D, Forus A, Myklebost O. Meza-Zepeda LA, et al. Genes Chromosomes Cancer. 2001 Jul;31(3):264-73. doi: 10.1002/gcc.1143. Genes Chromosomes Cancer. 2001. PMID: 11391797

6

A well-differentiated liposarcoma with a new type of chromosome 12-derived markers.

Forus A, Bjerkehagen B, Sirvent N, Meza-Zepeda LA, Coindre JM, Berner JM, Myklebost O, Pedeutour F. Forus A, et al. Cancer Genet Cytogenet. 2001 Nov;131(1):13-8. doi: 10.1016/s0165-4608(01)00516-7. Cancer Genet Cytogenet. 2001. PMID: 11734312

7

Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21.

Meza-Zepeda LA, Forus A, Lygren B, Dahlberg AB, Godager LH, South AP, Marenholz I, Lioumi M, Flørenes VA, Maelandsmo GM, Serra M, Mischke D, Nizetic D, Ragoussis J, Tarkkanen M, Nesland JM, Knuutila S, Myklebost O. Meza-Zepeda LA, et al. Oncogene. 2002 Mar 28;21(14):2261-9. doi: 10.1038/sj.onc.1205339. Oncogene. 2002. PMID: 11948409

8

Amplification of chromosome 1 sequences in lipomatous tumors and other sarcomas.

Nilsson M, Meza-Zepeda LA, Mertens F, Forus A, Myklebost O, Mandahl N. Nilsson M, et al. Int J Cancer. 2004 Apr 10;109(3):363-9. doi: 10.1002/ijc.11716. Int J Cancer. 2004. PMID: 14961574 Free article.

9

M-CGH: analysing microarray-based CGH experiments.

Wang J, Meza-Zepeda LA, Kresse SH, Myklebost O. Wang J, et al. BMC Bioinformatics. 2004 Jun 9;5:74. doi: 10.1186/1471-2105-5-74. BMC Bioinformatics. 2004. PMID: 15189572 Free PMC article.

10

Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas.

Galteland E, Sivertsen EA, Svendsrud DH, Smedshammer L, Kresse SH, Meza-Zepeda LA, Myklebost O, Suo Z, Mu D, Deangelis PM, Stokke T. Galteland E, et al. Leukemia. 2005 Dec;19(12):2313-23. doi: 10.1038/sj.leu.2403954. Leukemia. 2005. PMID: 16193090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page